Form 4: NuCana COO Theresa Bruce Receives Large Option Grant
Statement of Changes in Beneficial Ownership
NuCana plc Chief Operating Officer Theresa Bruce was granted 132,600,130 stock options on April 15, 2026.
Summary
- Theresa Bruce, Chief Operating Officer of NuCana plc, received a grant of 132,600,130 stock options.
- The options have an exercise price of 0.0004 Pounds Sterling per share.
- The options vest 50% on April 15, 2026, with the remaining 50% vesting in four equal annual installments.
- The options expire on April 15, 2036.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative disclosure regarding executive compensation, which is standard practice and does not inherently signal a change in company performance.
Positives
- The grant aligns the interests of the Chief Operating Officer with long-term shareholder value through equity-based compensation.
Negatives
- The issuance of a significant number of options may lead to future shareholder dilution upon exercise.
Risks
- The vesting of these options is contingent upon the continued service of the Reporting Person with the Company.
Future Outlook
The filing does not provide forward-looking financial guidance, focusing solely on the disclosure of an executive equity grant.
Industry Context
StockSavvy.ai notes that large equity grants to C-suite executives in the biotechnology sector are common mechanisms for retention and performance incentivization, though the scale of this specific grant is notable relative to typical executive compensation packages.
Comparison to Industry Standards
- The use of long-term vesting schedules (four years) is consistent with standard corporate governance practices in the UK and US biotech sectors.
- The exercise price set at the nominal value of the shares is a specific compensation structure often seen in early-stage or high-growth biotech firms.
Stakeholder Impact
- Existing shareholders may face potential dilution if these options are exercised in the future.
Next Steps
- Vesting of the remaining 50% of options in four equal annual installments subject to continued service.
Key Dates
| Date | Description |
|---|---|
| 04/15/2026 | Transaction date of the option grant and initial vesting date. |
| 04/16/2026 | Date of filing. |
| 04/15/2036 | Expiration date of the granted options. |
Keywords
NuCana, NCNA, Form 4, Insider Trading, Stock Options, Executive Compensation
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.